Barbara Vischioni

National Center for Oncological Hadrontherapy

Papers

1

Total Citations

18

H-Index

1

About

Dr. Barbara Vischioni is a leading figure in hadrontherapy, a cutting-edge form of radiation oncology. Her primary research focuses on the clinical application of proton and carbon ion beams, particularly for treating complex tumors like chordomas and chondrosarcomas. As a key clinician at the Italian National Center for Hadrontherapy (CNAO), Dr. Vischioni has been instrumental in pioneering scanned proton beam therapy in Italy. Her landmark 2013 paper, "Initial clinical experience with scanned proton beams at CNAO," (18 citations) reported the first toxicity data from patients treated under Phase II protocols, establishing the safety and feasibility of this advanced technique. This foundational work paved the way for broader clinical adoption. Dr. Vischioni’s contributions extend to optimizing treatment protocols for skull base and spinal tumors, where precise dose delivery is critical. Her research consistently demonstrates how hadrontherapy can achieve superior tumor control while minimizing damage to surrounding healthy tissue, directly improving patient quality of life. Through her clinical trials and publications, Dr. Vischioni has helped position CNAO as a global reference center for particle therapy, advancing the field from experimental physics into routine, life-saving clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)
18 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Center for Oncological Hadrontherapy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago